Limited Access Protocol for the Use of Oral Cisapride in the Treatment of Refractory Gastroesophageal Reflux Disease and Other Gastrointestinal Motility Disorders
-
- STATUS
- Not Recruiting
Summary
The purpose of this investigational limited access program is to allow the use of cisapride by patients with gastroesophageal reflux disease (a flow of stomach and small intestinal contents into the feeding tube) and other gastrointestinal motility disord
Description
The purpose of this investigational limited access program is to allow the use of cisapride by patients with gastroesophageal reflux disease (a flow of stomach and small intestinal contents into the feeding tube) and other gastrointestinal motility disord
Details
| Condition | Gastroesophageal Reflux Disease |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX2608 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.